Enovix Corp (ENVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,014 | 272,869 | 233,121 | 322,851 | 385,293 |
| Marketable Securities | 406,026 | N/A | 73,694 | N/A | N/A |
| Receivables | 4,421 | 4,566 | 909 | 170 | N/A |
| Inventories | 13,617 | 7,664 | 8,737 | 634 | N/A |
| Other current assets | 4,012 | 4 | 1,514 | 0 | 4,554 |
| TOTAL | $542,210 | $295,006 | $323,177 | $329,648 | $398,121 |
| Non-Current Assets | |||||
| PPE Net | 170,263 | 167,947 | 166,471 | 103,868 | 76,613 |
| Investments And Advances | 106,810 | 0 | 0 | 0 | 0 |
| Intangibles | 43,855 | 48,611 | 54,266 | 0 | 0 |
| Other Non-Current Assets | 15,837 | 15,605 | 20,390 | 7,070 | 7,831 |
| TOTAL | $336,765 | $232,163 | $241,127 | $110,938 | $84,444 |
| Total Assets | $878,975 | $527,169 | $564,304 | $440,586 | $482,565 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,865 | 9,452 | 5,917 | N/A | N/A |
| Accounts payable and accrued liabilities | 17,818 | 9,492 | 21,251 | 7,077 | 3,144 |
| Accrued Expenses | 20,211 | 28,071 | 24,707 | 15,186 | 11,210 |
| Other current liabilities | 12,107 | 3,036 | 2,435 | 716 | 707 |
| TOTAL | $65,016 | $53,701 | $61,018 | $23,029 | $20,636 |
| Non-Current Liabilities | |||||
| Long Term Debt | 519,271 | 169,820 | 169,099 | N/A | N/A |
| Deferred Revenues | 5,015 | 3,650 | 6,708 | 50 | 5,575 |
| Other Non-Current Liabilities | 11,124 | 41,980 | 58,568 | 57,406 | 133,522 |
| TOTAL | $539,948 | $224,065 | $242,183 | $61,130 | $135,812 |
| Total Liabilities | $604,964 | $277,766 | $303,201 | $84,159 | $156,448 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 217,224 | 191,274 | 168,504 | 157,780 | 156,481 |
| Common Shares | 22 | 19 | 17 | 15 | 15 |
| Retained earnings | -977,827 | -821,086 | -598,845 | -384,774 | -333,152 |
| Other shareholders' equity | 1,904 | 2,519 | 2,894 | 0 | 0 |
| TOTAL | $274,011 | $249,403 | $261,103 | $356,427 | $326,117 |
| Total Liabilities And Equity | $878,975 | $527,169 | $564,304 | $440,586 | $482,565 |